- 210 567-5792
Adriel J. Malavé, MD, FCCP
Current pulmonary hypertension studies are looking into change in the delivery system or device of one of the inhaled prostacyclin, and it also looking into the changes in pharmacokinetics. Another study looked in the possible effects of pulmonary vasodilator in the setting of chronic lung disease.
Main interest are related to Pulmonary hypertension and lung cancer diagnosis. Involved in multiple industry sponsored Pulmonary hypertension studies.
Awards & Accomplishments
ACCP Steering Committee member of the Clinical Pulmonary Network
2015-2018 Top Doctors in Texas Rising Star: Top Doctors In Texas Rising Stars Recognition published in the July edition of the: Texas Monthly magazine
Pulmonary Hypertension Association
American college of chest physicians(ACCP)
1. Arora Anisha, Diaz Karla, Peters JI, Malavé AJ. Bronchoscopy and otherDiagnostic Studies (Chapter 13) In: Shelledy DC, Peters JI. Respiratory Care: Patient Assessment and Care Plan Development. Burlington, Mass: Jones and Bartlett; 2014. p. 543 – 555.
2. Malavé AJ, Proud,K. Diagnostic and Supportive Procedures in the ICU (Chapter 12) in: Mechanical Ventilation 3rd Edition David C. Shelledy, PhD, RRT; Jay I. Peters, MD Burlington, Mass: Jones and Bartlett; 2019. p. 559 – 575.
1. Malavé AJ, Maurer J, Tanoue L, Willsie S, Shafazand S. Year Book of Pulmonary Disease 2016. Vol 2016
1.Malavé AJ, Laserna E, Sibila O, Mortensen EM, Anzueto AR, Restrepo MI.Impact of prior systemic corticosteroid use in patients admitted with community-acquired pneumonia. Ther Adv Respir Dis 2012 Dec;6(6):323-330